Reading Time: < 1 minute I’m glad to finally announce that UK recruitment for the dexpramipexole clinical trial is now open! So far, we are aware that Liverpool has opened
Reading Time: 2 minutes Would it ever cross your mind that the relative lengths of your fingers might be related to the durability of your motor neurones? Probably not
Reading Time: 2 minutes We organise the International Symposium on ALS/MND every year, and this year, the symposium will be going ‘down under’ to Sydney Australia on 30 November
Reading Time: 2 minutes We have been made aware that there’s a new kid on the block in terms of unproven treatments, which is a new route of administration
Reading Time: < 1 minute In the past year, our blog has been viewed nearly 16,000 times. We’ve written 97 articles to take people behind the scenes of MND research,
Reading Time: < 1 minute We’re aware that thing’s may seem quiet in terms of ‘big’ MND research moments… almost too quiet… Well, today, the pharmaceutical companies Biogen Idec and Knopp Biosciences announced
Reading Time: < 1 minute As we’ve mentioned in previous posts, our current research grants round is our biggest yet with 19 full applications being reviewed by our research advisory
Reading Time: 2 minutes Form filling is tedious. For those of us of a certain age (I’m not saying any more!) online form filling is even more stressful. So recently,
Reading Time: 2 minutes An unproven treatment called ‘Spirulina’, which is a type of blue-green algae, has recently been investigated by ALSUntangled*. They concluded that there is no evidence
Reading Time: 3 minutes A study led by MND Association funded researcher Prof Siddharthan Chandran from the University of Edinburgh has developed a new method to create a diverse group